Standout Papers

Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrop... 2020 2026 2022 2024247
  1. Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy (2020)
    Jerry R. Mendell, Zarife Sahenk et al. JAMA Neurology

Immediate Impact

63 standout
Sub-graph 1 of 22

Citing Papers

Targeting and engineering long non-coding RNAs for cancer therapy
2024 Standout
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
2024 Standout
3 intermediate papers

Works of A. Dugar being referenced

A Combined Prospective and Retrospective Comparison of Long-Term Functional Outcomes Suggests Delayed Loss of Ambulation and Pulmonary Decline with Long-Term Eteplirsen Treatment
2021
Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy
2020 Standout

Author Peers

Author Last Decade Papers Cites
A. Dugar 70 283 28 129 114 22 591
Andrew Crowther 96 237 24 38 27 34 635
Keiko Matsuoka 24 80 28 117 195 22 703
Geoff Wallace 134 289 2 164 235 20 707
Hannu Heiskala 115 161 6 37 165 40 687
E. Veneselli 94 148 16 103 135 30 568
J L Signoret 98 106 61 40 90 20 643
Sakae Takahashi 43 138 39 106 120 32 571
A Turner 53 137 92 46 17 36 578
Ru Band Lu 189 219 22 80 238 16 701
Véronique Labelle 79 377 20 56 34 17 686

All Works

Loading papers...

Rankless by CCL
2026